Review



intravitreal injection  (Servicebio Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Servicebio Inc intravitreal injection
    Intravitreal Injection, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal injection/product/Servicebio Inc
    Average 86 stars, based on 1 article reviews
    intravitreal injection - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    intravitreal injection  (MedChemExpress)
    97
    MedChemExpress intravitreal injection
    Expression of MCM6 after <t>intravitreal</t> melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.
    Intravitreal Injection, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal injection/product/MedChemExpress
    Average 97 stars, based on 1 article reviews
    intravitreal injection - by Bioz Stars, 2026-05
    97/100 stars
    		  Buy from Supplier
    intravitreal injection  (Servicebio Inc)
    86
    Servicebio Inc intravitreal injection
    Expression of MCM6 after <t>intravitreal</t> melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.
    Intravitreal Injection, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal injection/product/Servicebio Inc
    Average 86 stars, based on 1 article reviews
    intravitreal injection - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    intravitreous injections  (MedChemExpress)
    94
    MedChemExpress intravitreous injections
    Expression of MCM6 after <t>intravitreal</t> melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.
    Intravitreous Injections, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreous injections/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    intravitreous injections - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease  (System Biosciences Inc)
    86
    System Biosciences Inc rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease
    Expression of MCM6 after <t>intravitreal</t> melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.
    Rat Ad Msc Ev39 Dr Ultracentrifugation Stz Induced Sd Rats Intravitreal Injection Significant Decrease, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease/product/System Biosciences Inc
    Average 86 stars, based on 1 article reviews
    rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    intravitreal ranibizumab injections  (Intas Pharmaceuticals)
    86
    Intas Pharmaceuticals intravitreal ranibizumab injections
    Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
    Intravitreal Ranibizumab Injections, supplied by Intas Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal ranibizumab injections/product/Intas Pharmaceuticals
    Average 86 stars, based on 1 article reviews
    intravitreal ranibizumab injections - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    intravitreal faricimab ivf injection  (Tenaya Therapeutics)
    86
    Tenaya Therapeutics intravitreal faricimab ivf injection
    Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
    Intravitreal Faricimab Ivf Injection, supplied by Tenaya Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal faricimab ivf injection/product/Tenaya Therapeutics
    Average 86 stars, based on 1 article reviews
    intravitreal faricimab ivf injection - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    intravitreal injection  (Novartis)
    86
    Novartis intravitreal injection
    Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
    Intravitreal Injection, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/intravitreal injection/product/Novartis
    Average 86 stars, based on 1 article reviews
    intravitreal injection - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    avacincaptad pegol zimura intravitreal injection  (Astellas)
    86
    Astellas avacincaptad pegol zimura intravitreal injection
    Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
    Avacincaptad Pegol Zimura Intravitreal Injection, supplied by Astellas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/avacincaptad pegol zimura intravitreal injection/product/Astellas
    Average 86 stars, based on 1 article reviews
    avacincaptad pegol zimura intravitreal injection - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of MCM6 after intravitreal melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response

    doi: 10.1167/iovs.66.15.14

    Figure Lengend Snippet: Expression of MCM6 after intravitreal melphalan chemotherapy in human retinoblastoma. ( A , B ) Immunohistochemical staining of MCM6 in human RB tissues from melphalan (Melp)-refractory cases ( A ) and percentage of MCM6 + cells compared with untreated RB tissues ( B ). Data are presented as mean ± SD ( n = 8 for untreated group; n = 6 for melphalan-refractory group), with significance assessed by unpaired two-tailed Student's t -test. ** P < 0.01.

    Article Snippet: On day 14 post-injection, mice received a single intravitreal injection of 1-μL melphalan (0.25 μg/μL in PBS, HY-17575; MedChemExpress, Monmouth Junction, NJ, USA) or vehicle.

    Techniques: Expressing, Immunohistochemical staining, Staining, Two Tailed Test

    Best corrected visual acuity (ETDRS Letters) Over Time in Innovator ranibizumab vs Biosimilar ranibizumab(Razumab) Groups.

    Journal: Clinical Ophthalmology (Auckland, N.Z.)

    Article Title: Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study

    doi: 10.2147/OPTH.S549744

    Figure Lengend Snippet: Best corrected visual acuity (ETDRS Letters) Over Time in Innovator ranibizumab vs Biosimilar ranibizumab(Razumab) Groups.

    Article Snippet: The study included patients diagnosed with myopic choroidal neovascular membrane (CNVM) who received intravitreal ranibizumab injections—either the innovator molecule (Lucentis/Accentrix ® , Novartis, Mumbai, India) or a biosimilar formulation (Razumab ® , Intas Pharmaceuticals Gujarat, India)—as part of their routine clinical care.

    Techniques:

    Central macular thickness Comparison Over Time: Innovator ranibizumab vs Biosimilar Ranibizumab (Razumab).

    Journal: Clinical Ophthalmology (Auckland, N.Z.)

    Article Title: Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study

    doi: 10.2147/OPTH.S549744

    Figure Lengend Snippet: Central macular thickness Comparison Over Time: Innovator ranibizumab vs Biosimilar Ranibizumab (Razumab).

    Article Snippet: The study included patients diagnosed with myopic choroidal neovascular membrane (CNVM) who received intravitreal ranibizumab injections—either the innovator molecule (Lucentis/Accentrix ® , Novartis, Mumbai, India) or a biosimilar formulation (Razumab ® , Intas Pharmaceuticals Gujarat, India)—as part of their routine clinical care.

    Techniques: Comparison